Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
Main Authors: | , , , , , , , , , , , |
---|---|
Formato: | Conference item |
Publicado em: |
AMER SOC HEMATOLOGY
2010
|